A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia
Clinical trial NCT04996030 · SUSPENDED
Trial details
- NCT number
- NCT04996030
- Sponsor
- Syros Pharmaceuticals
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-17
- Primary completion
- 2024-01-03
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.